Post by
MIA17 on Sep 17, 2009 8:52am
Approved in Mexico
$0$0YM Biosciences receives nimotuzumab approval in Mexico$0$0$0$0$02009-09-17 08:21 ET - News Release$0$0Mr. David Allan reports$0$0YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO; YM ENROLLS FIRST PATIENTS IN MULTINATIONAL RANDOMIZED, DOUBLE-BLIND BRAIN METASTASES TRIAL$0$0YM BioSciences Inc.'s nimotuzumab has been approved for marketing in Mexico. YM BioSciences has also enrolled the first two patients in its randomized, double-blind trial evaluating nimotuzumab in patients with brain metastases from non-small-cell lung cancer (NSCLC).$0$0"Mexico is the 21st country to have approved nimotuzumab for marketing and, while YM's licence for major market territories for nimotuzumab does not include Mexico, this approval reflects the growing recognition throughout much of the world of the value to patients of our drug and the progress being made in its commercialization," said David Allan, chairman and chief executive officer of YM BioSciences. "As part of YM's registration strategy for nimotuzumab, we were also pleased to report the opening of this second of two randomized, double-blind trials that YM is conducting in Canada and which are both now being expanded internationally."$0